GUELPH, ON, Aug. 26, 2024 /PRNewswire/ — Discover a revolutionary path to mental wellness and personal success with Lori Gradley’s latest book, How to Think and Succeed by Empowering Your Mind. With over 35 years of experience in personal development training, she presents this self-help guide designed to unlock your hidden potential, create a positive mindset, and pave the way to a life of happiness and abundance.
This revolutionary book takes readers on an enlightening journey of self-discovery, blending timeless principles of personal growth with cutting-edge mental tools. Through Lori’s insightful wisdom, actionable strategies, and exercises she empowers readers to break through mental barriers, foster resilience, and cultivate a mindset of boundless positivity.
Key Benefits of This Game-Changing Book:
“This book is a masterpiece,” says Mental Health Therapist D. Jamison. “It blends years of wellness experience with scientific strategies & heartfelt life lessons that offers practical solutions to becoming your best self.”
Dr. L. Brown, MD describes it as “a deep, thought-provoking exploration of inspiration and the science behind a positive mindset.”
Available in multiple formats & distribution channels. This book is a must-read for anyone looking to elevate their mental health & personal success. Contact Lori Gradley at: 381610@email4pr.com request a Media Kit or call (905) 541-6636. Visit our sites at: www.lorigradley.com or https://splendidinspiration.com.
About the Author: Lori Gradley is an international writer, author and mindset coach who has been transforming lives for over three decades. As the founder of Splendid Inspiration, she offers life-changing online wellness courses and personalized coaching supporting people to become the best they can be. Based in Ontario, Canada, she is a loving mother & wife with a flair for writing, crafting empowering content dedicated to inspiring individuals worldwide.
SOURCE Lori Gradley
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…